ChartMillSeptember 7, 2026 at 6:23 AM NYLast Month
Arcutis Biotherapeutics (NASDAQ:ARQT) Delivers High Growth with Improving Fundamentals
Arcutis (ARQT) passes Navellier's 8 growth rules: EPS, revenue, and cash flow surging. A top pick for growth investors.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: ChartMill
